Rheumatology Unit, Hospital Universitario de La Princesa, IIS-Princesa, Diego de León 62, 28006, Madrid, Spain.
Department of Medicine, Cátedra UAM-ROCHE, EPID-Future, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Rheumatol Int. 2022 Sep;42(9):1643-1652. doi: 10.1007/s00296-022-05153-w. Epub 2022 Jun 13.
COVID-19 has been related to several autoimmune diseases, triggering the appearance of autoantibodies and endothelial dysfunction. Current evidence has drawn attention to vasculitis-like phenomena and leukocytoclastic vasculitis in some COVID-19 patients. Moreover, it has been hypothesized that COVID-19 could induce flares of preexisting autoimmune disorders. Here, we present two patients with previously controlled IgA vasculitis who developed a renal and cutaneous flare of vasculitis after mild COVID-19, one of them with new-onset ANCA vasculitis. These patients were treated with glucocorticoids and immunosuppressants achieving successful response. We also provide a focused literature review and conclude that COVID-19 may be associated with triggering of vasculitis and could induce flares of previous autoimmune diseases.
COVID-19 与多种自身免疫性疾病有关,可引发自身抗体的出现和内皮功能障碍。目前的证据引起了人们对一些 COVID-19 患者出现血管炎样现象和白细胞碎裂性血管炎的关注。此外,有人假设 COVID-19 可能引发先前存在的自身免疫性疾病的发作。在这里,我们介绍了两名以前控制良好的 IgA 血管炎患者,他们在轻度 COVID-19 后出现了肾脏和皮肤血管炎发作,其中一名患者出现了新的 ANCA 血管炎。这些患者接受了糖皮质激素和免疫抑制剂治疗,取得了成功的反应。我们还提供了一份重点文献综述,并得出结论,COVID-19 可能与血管炎的触发有关,并可能引发先前自身免疫性疾病的发作。